Terrapinn reported that GSK committed £400 million over three years to construct a new 300,000-square-foot facility.
Public source
Publisher name
Public post
September 2025 felt like a low point for UK R&D investment, with big pharma scaling back commitments amid growing commercial and innovation hurdles. So one year down the…
Company
Terrapinn
Terrapinn events inspire and transform business.
- Industry
- Media Production
- Location
- London, GB
- Company size
- 501–1,000 employees
About Terrapinn
Terrapinn events inspire and transform business. We’ve been sparking ideas, innovations and relationships that transform business for over 30 years. Using our global footprint, we bring innovators, disrupters and change agents together. Discussing and demonstrating the technology, strategies and personalities that are changing the way the world does business. We are creative, organic and customer-focused, curating content for the specific industry and location of each event. Whether you’re looking to make new connections, introduce product or inspire change in your industry, we invite you to join us as agitators of change. We're hiring! We want people who think and act differently to work with us: change agitators who are curious and customer focused. A Terrapinn career will challenge you, be a great place to learn and have genuine international opportunity. Visit our website at www.terrapinn.com or contact any of our global offices to find out more about career opportunities. Terrapinn – spark something.
See moreLatest activity
Latest activity from Terrapinn
41 signals
Presence & Recognition
Terrapinn marked World EV Day with free charging across its national AC network and selected rapid and ultra-rapid hubs on September 9.
Presence & Recognition
Terrapinn attended Identity Week America 2026 and showcased its expertise in identity, fraud, and security.
Presence & Recognition
Terrapinn is exhibiting at Connected Britain 2026 at Stand O55.
Discover more
Similar signals
Similar public activity from other companies.
Capital & Finance
GlobalData Healthcare
GlobalData Healthcare announced a $2.3bn investment in a new Houston campus featuring multi-modal capability and modular construction built from the start.
Capital & Finance
6M Group LLC
6M Group LLC reported that GSK expanded its footprint into Cambridge.
Capital & Finance
Protel Projects
Protel Projects notes that Cambrex Milan Constructs is opening a new $30m R&D facility in Italy to celebrate its 80th anniversary.
Capital & Finance
iiCON: Infection Innovation Consortium
iiCON: Infection Innovation Consortium launched the Liverpool Accelerate Laboratory, a £20 million UK-first high-security facility located at the Liverpool School of Tropical Medicine developed through the consortium, which will accelerate the fight against deadly infections and phase out animal testing.
Capital & Finance
AGC Biologics